Humana Inc. (NYSE:HUM) Shares Purchased by Victory Capital Management Inc.

Victory Capital Management Inc. boosted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 73.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 184,937 shares of the insurance provider's stock after acquiring an additional 78,351 shares during the period. Victory Capital Management Inc. owned about 0.15% of Humana worth $46,920,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in HUM. Transcend Capital Advisors LLC raised its position in shares of Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after buying an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC raised its position in shares of Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after buying an additional 26,856 shares during the last quarter. Retirement Systems of Alabama raised its position in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after buying an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after buying an additional 65,735 shares during the last quarter. Finally, PDT Partners LLC raised its position in shares of Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock valued at $1,286,000 after buying an additional 2,660 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. StockNews.com cut shares of Humana from a "buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Royal Bank of Canada reiterated an "outperform" rating and issued a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Truist Financial increased their target price on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research report on Monday, January 6th. JPMorgan Chase & Co. dropped their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Finally, Morgan Stanley dropped their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Twenty analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $285.68.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.32% of the company's stock.

Humana Trading Down 0.4 %

HUM stock traded down $1.04 during mid-day trading on Tuesday, hitting $250.21. 1,387,813 shares of the company were exchanged, compared to its average volume of 1,676,635. The business has a fifty day simple moving average of $271.67 and a 200-day simple moving average of $281.65. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The firm has a market capitalization of $30.19 billion, a P/E ratio of 25.15, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.